Alam Kamran
CHIEF FINANCIAL OFFICER
Alam Kamran has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Feb 6, 2026.
On the most recent filing, Alam Kamran is listed as CHIEF FINANCIAL OFFICER at Taysha Gene Therapies, Inc. Inside the rolling window, Alam Kamran reported no open-market purchases and 3 open-market sales totaling $493K in TSHA. The largest disclosed transaction in the window is a sale of 78,968 TSHA shares on Jan 23, 2026, worth $375K.
Companies traded
Other insiders at TSHA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$493K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Alam Kamran made?
Alam Kamran has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does Alam Kamran trade?
Alam Kamran has filed SEC Form 4 disclosures for 1 company, including TSHA.
When was Alam Kamran's most recent SEC Form 4 filing?
Alam Kamran's most recent SEC Form 4 filing on Tracefour is dated Feb 6, 2026.
What is Alam Kamran's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Alam Kamran is listed as CHIEF FINANCIAL OFFICER.
What is Alam Kamran's total buy and sell value in the current window?
Inside the rolling retention window, Alam Kamran bought $0 and sold $493K based on SEC Form 4 filings.
What was Alam Kamran's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 78,968 TSHA shares on 2026-01-23, worth $375K, per SEC Form 4 filings.